Additionally, the health IT company’s fiscal year revenue totaled $179 billion, up 30 percent from the $137.4 billion the previous year.
McKesson’s reported profit for the last quarter was $132 million, a 64 percent decrease from $370 million during the same time last year, according to a Wall Street Journal report, which suggests part of the decline is due to a $150 million settlement with the U.S. government for charges related to order reporting practices for controlled substances.
More articles on health IT:
Criminal attacks No. 1 cause of healthcare data breaches: 5 things to know
Allscripts stock leaps 5.7%: 3 things to know
78M consumers worldwide to use home health technologies by 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
